Association of HLA-B1502 allele with lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese subjects: a meta-analysis
Background Despite several studies investigating the association between the human leukocyte antigen HLA‐B*1502 allele and lamotrigine‐induced Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Han Chinese subjects, the relationship remains unclear. Objectives We performed a syst...
Saved in:
| Published in | International journal of dermatology Vol. 54; no. 4; pp. 488 - 493 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Blackwell Publishing Ltd
01.04.2015
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0011-9059 1365-4632 1365-4632 |
| DOI | 10.1111/ijd.12570 |
Cover
Loading…
| Abstract | Background
Despite several studies investigating the association between the human leukocyte antigen HLA‐B*1502 allele and lamotrigine‐induced Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Han Chinese subjects, the relationship remains unclear.
Objectives
We performed a systematic review and meta‐analysis to ascertain the association between the HLA‐B*1502 allele and lamotrigine‐induced SJS and TEN in Han Chinese populations.
Methods
We searched the biomedical literature archived in the MEDLINE, Cochrane Library, EMBASE, Chinese Biomedical, Chinese National Knowledge Infrastructure, and China Science and Technology Journal databases. Only studies investigating the association between HLA‐B*1502 and lamotrigine‐induced SJS/TEN were included. We then performed a meta‐analysis of the data in these studies.
Results
Four studies including a total of 12 patients with SJS/TEN and 128 lamotrigine‐tolerant control subjects were identified. The HLA‐B*1502 allele was present in 33.3% (four of 12) of lamotrigine‐induced SJS/TEN cases but in only 9.4% (12 of 128) of lamotrigine‐tolerant controls. The occurrence of SJS/TEN was thus associated with the presence of the HLA‐B*1502 allele (odds ratio: 4.98, 95% confidence interval 1.43–17.28; P < 0.05).
Conclusions
We found a statistical association between HLA‐B*1502 and lamotrigine‐induced SJS/TEN in Han Chinese subjects. Future studies with larger sample sizes are suggested to verify the results. |
|---|---|
| AbstractList | Despite several studies investigating the association between the human leukocyte antigen HLA-B*1502 allele and lamotrigine-induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Han Chinese subjects, the relationship remains unclear.
We performed a systematic review and meta-analysis to ascertain the association between the HLA-B*1502 allele and lamotrigine-induced SJS and TEN in Han Chinese populations.
We searched the biomedical literature archived in the MEDLINE, Cochrane Library, EMBASE, Chinese Biomedical, Chinese National Knowledge Infrastructure, and China Science and Technology Journal databases. Only studies investigating the association between HLA-B*1502 and lamotrigine-induced SJS/TEN were included. We then performed a meta-analysis of the data in these studies.
Four studies including a total of 12 patients with SJS/TEN and 128 lamotrigine-tolerant control subjects were identified. The HLA-B*1502 allele was present in 33.3% (four of 12) of lamotrigine-induced SJS/TEN cases but in only 9.4% (12 of 128) of lamotrigine-tolerant controls. The occurrence of SJS/TEN was thus associated with the presence of the HLA-B*1502 allele (odds ratio: 4.98, 95% confidence interval 1.43-17.28; P < 0.05).
We found a statistical association between HLA-B*1502 and lamotrigine-induced SJS/TEN in Han Chinese subjects. Future studies with larger sample sizes are suggested to verify the results. Despite several studies investigating the association between the human leukocyte antigen HLA-B*1502 allele and lamotrigine-induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Han Chinese subjects, the relationship remains unclear.BACKGROUNDDespite several studies investigating the association between the human leukocyte antigen HLA-B*1502 allele and lamotrigine-induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Han Chinese subjects, the relationship remains unclear.We performed a systematic review and meta-analysis to ascertain the association between the HLA-B*1502 allele and lamotrigine-induced SJS and TEN in Han Chinese populations.OBJECTIVESWe performed a systematic review and meta-analysis to ascertain the association between the HLA-B*1502 allele and lamotrigine-induced SJS and TEN in Han Chinese populations.We searched the biomedical literature archived in the MEDLINE, Cochrane Library, EMBASE, Chinese Biomedical, Chinese National Knowledge Infrastructure, and China Science and Technology Journal databases. Only studies investigating the association between HLA-B*1502 and lamotrigine-induced SJS/TEN were included. We then performed a meta-analysis of the data in these studies.METHODSWe searched the biomedical literature archived in the MEDLINE, Cochrane Library, EMBASE, Chinese Biomedical, Chinese National Knowledge Infrastructure, and China Science and Technology Journal databases. Only studies investigating the association between HLA-B*1502 and lamotrigine-induced SJS/TEN were included. We then performed a meta-analysis of the data in these studies.Four studies including a total of 12 patients with SJS/TEN and 128 lamotrigine-tolerant control subjects were identified. The HLA-B*1502 allele was present in 33.3% (four of 12) of lamotrigine-induced SJS/TEN cases but in only 9.4% (12 of 128) of lamotrigine-tolerant controls. The occurrence of SJS/TEN was thus associated with the presence of the HLA-B*1502 allele (odds ratio: 4.98, 95% confidence interval 1.43-17.28; P < 0.05).RESULTSFour studies including a total of 12 patients with SJS/TEN and 128 lamotrigine-tolerant control subjects were identified. The HLA-B*1502 allele was present in 33.3% (four of 12) of lamotrigine-induced SJS/TEN cases but in only 9.4% (12 of 128) of lamotrigine-tolerant controls. The occurrence of SJS/TEN was thus associated with the presence of the HLA-B*1502 allele (odds ratio: 4.98, 95% confidence interval 1.43-17.28; P < 0.05).We found a statistical association between HLA-B*1502 and lamotrigine-induced SJS/TEN in Han Chinese subjects. Future studies with larger sample sizes are suggested to verify the results.CONCLUSIONSWe found a statistical association between HLA-B*1502 and lamotrigine-induced SJS/TEN in Han Chinese subjects. Future studies with larger sample sizes are suggested to verify the results. Background Despite several studies investigating the association between the human leukocyte antigen HLA‐B*1502 allele and lamotrigine‐induced Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Han Chinese subjects, the relationship remains unclear. Objectives We performed a systematic review and meta‐analysis to ascertain the association between the HLA‐B*1502 allele and lamotrigine‐induced SJS and TEN in Han Chinese populations. Methods We searched the biomedical literature archived in the MEDLINE, Cochrane Library, EMBASE, Chinese Biomedical, Chinese National Knowledge Infrastructure, and China Science and Technology Journal databases. Only studies investigating the association between HLA‐B*1502 and lamotrigine‐induced SJS/TEN were included. We then performed a meta‐analysis of the data in these studies. Results Four studies including a total of 12 patients with SJS/TEN and 128 lamotrigine‐tolerant control subjects were identified. The HLA‐B*1502 allele was present in 33.3% (four of 12) of lamotrigine‐induced SJS/TEN cases but in only 9.4% (12 of 128) of lamotrigine‐tolerant controls. The occurrence of SJS/TEN was thus associated with the presence of the HLA‐B*1502 allele (odds ratio: 4.98, 95% confidence interval 1.43–17.28; P < 0.05). Conclusions We found a statistical association between HLA‐B*1502 and lamotrigine‐induced SJS/TEN in Han Chinese subjects. Future studies with larger sample sizes are suggested to verify the results. |
| Author | Zeng, Tao Long, Yue-Sheng Min, Fu-Li Liao, Wei-Ping Shi, Yi-Wu |
| Author_xml | – sequence: 1 givenname: Tao surname: Zeng fullname: Zeng, Tao organization: Institute of Neuroscience and the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China – sequence: 2 givenname: Yue-Sheng surname: Long fullname: Long, Yue-Sheng organization: Institute of Neuroscience and the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China – sequence: 3 givenname: Fu-Li surname: Min fullname: Min, Fu-Li organization: Institute of Neuroscience and the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China – sequence: 4 givenname: Wei-Ping surname: Liao fullname: Liao, Wei-Ping organization: Institute of Neuroscience and the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China – sequence: 5 givenname: Yi-Wu surname: Shi fullname: Shi, Yi-Wu email: stoneyiwu@163.comstoneyiwu@sohu.com organization: Institute of Neuroscience and the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25428396$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kc1u1DAYRS1URKeFBS-AvIRFWv8kTsNuOkCnVQQSVAKxsRz7C-PBsYfYoZ1H4W0xM20XSOCNZemcK13fI3TggweEnlNyQvM5tWtzQllVk0doRrmoilJwdoBmhFBaNKRqDtFRjOv85IyWT9Ahq0p2xhsxQ7_mMQZtVbLB49DjZTsvzmlFGFbOgQN8Y9MKOzWENNpv1kNhvZk0GPwpwU_wsbgKKx-zHLfejGEArLzBKdxajWFjDYyDctiDHoPbRhux9XipPF6sclgEHKduDTrF11jhAZIqlFc78Cl63CsX4dndfYyu3729XiyL9sPF5WLeFpoLTgpDetrRjvGuLjmQPreiTe6pcj9T8q4xui9ZL6juqQFVqrOeARBBFKO0MvwYvdzHbsbwY4KY5GCjBueUhzBFSYUQNeOCVBl9cYdO3QBGbkY7qHEr738zA6_2QC4b4wj9A0KJ_LOUzEvJ3VKZPf2L1TbtZkijsu5_xo11sP13tLy8enNvFHvDxgS3D4Yav0tR87qSn99fyLZlXyn7UsqP_DdO9LSc |
| CitedBy_id | crossref_primary_10_1007_s40291_018_0330_3 crossref_primary_10_1111_exd_14240 crossref_primary_10_1055_a_1312_7175 crossref_primary_10_2217_pgs_15_128 crossref_primary_10_1371_journal_pone_0278839 crossref_primary_10_1016_j_eplepsyres_2015_09_011 crossref_primary_10_1097_FPC_0000000000000531 crossref_primary_10_4155_bio_2023_0183 crossref_primary_10_3389_fphar_2023_1106423 crossref_primary_10_1097_FPC_0000000000000397 crossref_primary_10_1097_SCS_0000000000006662 crossref_primary_10_1155_2018_6431694 crossref_primary_10_3390_jcm13123563 crossref_primary_10_1212_WNL_0000000000007518 crossref_primary_10_2217_pme_2022_0126 crossref_primary_10_1016_j_jaip_2018_05_004 crossref_primary_10_1097_PEC_0000000000000840 crossref_primary_10_3390_jpm11050383 crossref_primary_10_1002_phar_2797 crossref_primary_10_1097_MD_0000000000023929 crossref_primary_10_3389_fphar_2016_00396 crossref_primary_10_1111_bcp_15818 crossref_primary_10_2217_pgs_2017_0041 crossref_primary_10_3389_fphar_2020_567048 crossref_primary_10_1016_j_anai_2017_02_011 crossref_primary_10_1080_23808993_2020_1732203 crossref_primary_10_2174_2772270817666230821102441 crossref_primary_10_1016_j_seizure_2019_07_003 crossref_primary_10_1016_j_survophthal_2016_01_004 crossref_primary_10_1590_abd1806_4841_20175070 crossref_primary_10_3390_biomedicines11010177 |
| Cites_doi | 10.1001/archderm.1990.01670320127028 10.1038/428486a 10.1111/j.1346-8138.2008.00548.x 10.1111/j.1528-1167.2007.01022.x 10.1016/j.seizure.2011.02.003 10.1111/j.1528-1167.2010.02533.x 10.4103/0378-6323.57718 10.1111/j.1528-1167.2010.02766.x 10.1212/WNL.0b013e31823b478c 10.1111/j.1365-4632.2010.04745.x 10.1016/j.eplepsyres.2011.08.010 10.1038/sj.tpj.6500356 10.1097/CCM.0b013e31821201ed 10.1007/s00228-011-1009-4 10.1111/j.1528-1167.2008.01719.x 10.1097/FPC.0b013e3282f3ef9c 10.1038/clpt.2012.189 10.1111/j.1533-2500.2011.00479.x 10.1093/hmg/ddq537 10.2217/14622416.9.11.1617 10.1001/archderm.1987.01660330077013 10.1056/NEJM199411103311906 10.1016/j.eplepsyres.2010.10.006 10.2340/00015555-0528 10.1056/NEJMoa1009717 10.1001/archderm.1990.01670250043005 10.1097/FPC.0b013e32832c347d 10.1016/j.yebeh.2010.08.007 10.1001/archderm.1991.01680050083008 10.1016/j.seizure.2011.01.005 10.1111/j.1742-7843.2011.00681.x 10.1111/j.1528-1167.2009.02269.x 10.2217/pgs.09.162 10.1016/j.yebeh.2010.11.022 10.1001/archderm.1991.01680050075007 10.2217/14622416.9.10.1543 10.1001/archderm.1990.01670250049006 |
| ContentType | Journal Article |
| Copyright | 2014 The International Society of Dermatology 2014 The International Society of Dermatology. |
| Copyright_xml | – notice: 2014 The International Society of Dermatology – notice: 2014 The International Society of Dermatology. |
| DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1111/ijd.12570 |
| DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1365-4632 |
| EndPage | 493 |
| ExternalDocumentID | 25428396 10_1111_ijd_12570 IJD12570 ark_67375_WNG_LL2Z12X4_R |
| Genre | article Research Support, Non-U.S. Gov't Meta-Analysis Journal Article |
| GrantInformation_xml | – fundername: National Natural Science Foundation funderid: 81271434; 81071045; 31070928 – fundername: Guangzhou Municipal College funderid: 12A017G |
| GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 29J 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AAQQT AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHEFC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 CYRXZ D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M J5H K48 KBYEO L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAHQN AAIPD AAMMB AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AEFGJ AEYWJ AFWVQ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY ALVPJ AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c3630-d0f1b1b23b743e0f39619132a839d43b9dcf42f61cf1dea4a8f2ee060a2115d3 |
| IEDL.DBID | DR2 |
| ISSN | 0011-9059 1365-4632 |
| IngestDate | Fri Jul 11 00:54:45 EDT 2025 Thu Apr 03 06:52:13 EDT 2025 Thu Apr 24 23:05:41 EDT 2025 Tue Jul 01 04:10:13 EDT 2025 Wed Aug 20 07:26:38 EDT 2025 Wed Oct 30 09:57:32 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| License | 2014 The International Society of Dermatology. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3630-d0f1b1b23b743e0f39619132a839d43b9dcf42f61cf1dea4a8f2ee060a2115d3 |
| Notes | Guangzhou Municipal College - No. 12A017G istex:32CFA90BA9066E5747FB9A3ED30C4128991DAD5F ArticleID:IJD12570 ark:/67375/WNG-LL2Z12X4-R National Natural Science Foundation - No. 81271434; No. 81071045; No. 31070928 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| PMID | 25428396 |
| PQID | 1666723605 |
| PQPubID | 23479 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_1666723605 pubmed_primary_25428396 crossref_primary_10_1111_ijd_12570 crossref_citationtrail_10_1111_ijd_12570 wiley_primary_10_1111_ijd_12570_IJD12570 istex_primary_ark_67375_WNG_LL2Z12X4_R |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2015-04 April 2015 2015-04-00 2015-Apr 20150401 |
| PublicationDateYYYYMMDD | 2015-04-01 |
| PublicationDate_xml | – month: 04 year: 2015 text: 2015-04 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | International journal of dermatology |
| PublicationTitleAlternate | Int J Dermatol |
| PublicationYear | 2015 |
| Publisher | Blackwell Publishing Ltd |
| Publisher_xml | – name: Blackwell Publishing Ltd |
| References | Strom BL, Carson JL, Halpern AC, et al. A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures. Arch Dermatol 1991; 127: 831-838. Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004; 428: 486. Mehta TY, Prajapati LM, Mittal B, et al. Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol 2009; 75: 579-582. Kashiwagi M, Aihara M, Takahashi Y, et al. Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients. J Dermatol 2008; 35: 683-685. Tassaneeyakul W, Tiamkao S, Jantararoungtong T, et al. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia 2010; 51: 926-930. Locharernkul C, Loplumlert J, Limotai C, et al. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia 2008; 49: 2087-2091. Wang Q, Zhou JQ, Zhou LM, et al. Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland. Seizure 2011; 20: 446-448. Schopf E, Stuhmer A, Rzany B, et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 1991; 127: 839-842. Kaniwa N, Saito Y, Aihara M, et al. HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Epilepsia 2010; 51: 2461-2465. Ferrell PB Jr, McLeod HL. Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics 2008; 9: 1543-1546. Man CB, Kwan P, Baum L, et al. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 2007; 48: 1015-1018. Shi YW, Min FL, Liu XR, et al. HLA-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population. Basic Clin Pharmacol Toxicol 2011; 109: 42-46. Kano Y, Hirahara K, Asano Y, et al. HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions. Acta Derm Venereol 2008; 88: 616-618. Wu XT, Hu FY, An DM, et al. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China. Epilepsy Behav 2010; 19: 405-408. Hung SI, Chung WH, Liu ZS, et al. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics 2010; 11: 349-356. Kaniwa N, Saito Y, Aihara M, et al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 2008; 9: 1617-1622. Min FL, Shi YW, Liu XR, et al. HLA-B*1502 genotyping in two Chinese patients with phenytoin-induced Stevens-Johnson syndrome. Epilepsy Behav 2011; 20: 390-391. Kulkantrakorn K, Tassaneeyakul W, Tiamkao S, et al. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain. Pain Pract 2012; 12: 202-208. Ikeda H, Takahashi Y, Yamazaki E, et al. HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions. Epilepsia 2010; 51: 297-300. Kazeem GR, Cox C, Aponte J, et al. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics 2009; 19: 661-665. Then SM, Rani ZZ, Raymond AA, et al. Frequency of the HLA-B*1502 allele contributing to carbamazepine-induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients. Asian Pac J Allergy Immunol 2011; 29: 290-293. Chen P, Lin JJ, Lu CS, et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med 2011; 364: 1126-1133. Lonjou C, Borot N, Sekula P, et al. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 2008; 18: 99-107. Gerull R, Nelle M, Schaible T. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Crit Care Med 2011; 39: 1521-1532. Zhang Y, Wang J, Zhao LM, et al. Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients. Eur J Clin Pharmacol 2011; 67: 885-887. Yang CY, Dao RL, Lee TJ, et al. Severe cutaneous adverse reactions to antiepileptic drugs in Asians. Neurology 2011; 77: 2025-2033. Guillaume JC, Roujeau JC, Revuz J, et al. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Arch Dermatol 1987; 123: 1166-1170. Ozeki T, Mushiroda T, Yowang A, et al. Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet 2011; 20: 1034-1041. An DM, Wu XT, Hu FY, et al. Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population. Epilepsy Res 2010; 92: 226-230. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-1285. Kim SH, Lee KW, Song WJ, et al. Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans. Epilepsy Res 2011; 97: 190-197. Hu FY, Wu XT, An DM, et al. Phenytoin-induced Stevens-Johnson syndrome with negative HLA-B*1502 allele in mainland China: two cases. Seizure 2011; 20: 431-432. Roujeau JC, Guillaume JC, Fabre JP, et al. Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985. Arch Dermatol 1990; 126: 37-42. Chan HL, Stern RS, Arndt KA, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990; 126: 43-47. Lonjou C, Thomas L, Borot N, et al. A marker for Stevens-Johnson syndrome..: ethnicity matters. Pharmacogenomics J 2006; 6: 265-268. Yip VL, Marson AG, Jorgensen AL, et al. HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review. Clin Pharmacol Ther 2012; 92: 757-765. Naldi L, Locati F, Marchesi L, et al. Incidence of toxic epidermal necrolysis in Italy. Arch Dermatol 1990; 126: 1103-1104. Chang CC, Too CL, Murad S, et al. Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population. Int J Dermatol 2011; 50: 221-224. 2010; 11 1994; 331 1987; 123 1990; 126 2010; 19 2008; 18 2008; 9 2011; 97 2011; 77 2008; 35 2006; 6 2004; 428 2011; 39 2012; 12 2012; 92 2011; 109 2009; 75 2008; 49 2011; 50 2011; 20 2011; 67 2008; 88 2010; 92 2009; 19 1991; 127 2011; 29 2011; 364 2010; 51 2007; 48 e_1_2_7_5_1 Then SM (e_1_2_7_25_1) 2011; 29 e_1_2_7_4_1 Naldi L (e_1_2_7_3_1) 1990; 126 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 Kano Y (e_1_2_7_32_1) 2008; 88 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 Guillaume JC (e_1_2_7_41_1) 1987; 123 e_1_2_7_30_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_36_1 Strom BL (e_1_2_7_6_1) 1991; 127 e_1_2_7_37_1 e_1_2_7_38_1 e_1_2_7_39_1 |
| References_xml | – reference: Yang CY, Dao RL, Lee TJ, et al. Severe cutaneous adverse reactions to antiepileptic drugs in Asians. Neurology 2011; 77: 2025-2033. – reference: Yip VL, Marson AG, Jorgensen AL, et al. HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review. Clin Pharmacol Ther 2012; 92: 757-765. – reference: Hu FY, Wu XT, An DM, et al. Phenytoin-induced Stevens-Johnson syndrome with negative HLA-B*1502 allele in mainland China: two cases. Seizure 2011; 20: 431-432. – reference: Kaniwa N, Saito Y, Aihara M, et al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 2008; 9: 1617-1622. – reference: Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004; 428: 486. – reference: Chen P, Lin JJ, Lu CS, et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med 2011; 364: 1126-1133. – reference: Kulkantrakorn K, Tassaneeyakul W, Tiamkao S, et al. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain. Pain Pract 2012; 12: 202-208. – reference: Schopf E, Stuhmer A, Rzany B, et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 1991; 127: 839-842. – reference: Guillaume JC, Roujeau JC, Revuz J, et al. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Arch Dermatol 1987; 123: 1166-1170. – reference: Gerull R, Nelle M, Schaible T. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Crit Care Med 2011; 39: 1521-1532. – reference: Mehta TY, Prajapati LM, Mittal B, et al. Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol 2009; 75: 579-582. – reference: Strom BL, Carson JL, Halpern AC, et al. A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures. Arch Dermatol 1991; 127: 831-838. – reference: Then SM, Rani ZZ, Raymond AA, et al. Frequency of the HLA-B*1502 allele contributing to carbamazepine-induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients. Asian Pac J Allergy Immunol 2011; 29: 290-293. – reference: An DM, Wu XT, Hu FY, et al. Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population. Epilepsy Res 2010; 92: 226-230. – reference: Hung SI, Chung WH, Liu ZS, et al. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics 2010; 11: 349-356. – reference: Lonjou C, Thomas L, Borot N, et al. A marker for Stevens-Johnson syndrome..: ethnicity matters. Pharmacogenomics J 2006; 6: 265-268. – reference: Naldi L, Locati F, Marchesi L, et al. Incidence of toxic epidermal necrolysis in Italy. Arch Dermatol 1990; 126: 1103-1104. – reference: Lonjou C, Borot N, Sekula P, et al. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 2008; 18: 99-107. – reference: Locharernkul C, Loplumlert J, Limotai C, et al. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia 2008; 49: 2087-2091. – reference: Ikeda H, Takahashi Y, Yamazaki E, et al. HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions. Epilepsia 2010; 51: 297-300. – reference: Kazeem GR, Cox C, Aponte J, et al. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics 2009; 19: 661-665. – reference: Kano Y, Hirahara K, Asano Y, et al. HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions. Acta Derm Venereol 2008; 88: 616-618. – reference: Roujeau JC, Guillaume JC, Fabre JP, et al. Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985. Arch Dermatol 1990; 126: 37-42. – reference: Zhang Y, Wang J, Zhao LM, et al. Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients. Eur J Clin Pharmacol 2011; 67: 885-887. – reference: Wang Q, Zhou JQ, Zhou LM, et al. Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland. Seizure 2011; 20: 446-448. – reference: Chan HL, Stern RS, Arndt KA, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990; 126: 43-47. – reference: Min FL, Shi YW, Liu XR, et al. HLA-B*1502 genotyping in two Chinese patients with phenytoin-induced Stevens-Johnson syndrome. Epilepsy Behav 2011; 20: 390-391. – reference: Kim SH, Lee KW, Song WJ, et al. Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans. Epilepsy Res 2011; 97: 190-197. – reference: Kashiwagi M, Aihara M, Takahashi Y, et al. Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients. J Dermatol 2008; 35: 683-685. – reference: Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-1285. – reference: Tassaneeyakul W, Tiamkao S, Jantararoungtong T, et al. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia 2010; 51: 926-930. – reference: Man CB, Kwan P, Baum L, et al. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 2007; 48: 1015-1018. – reference: Ozeki T, Mushiroda T, Yowang A, et al. Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet 2011; 20: 1034-1041. – reference: Chang CC, Too CL, Murad S, et al. Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population. Int J Dermatol 2011; 50: 221-224. – reference: Kaniwa N, Saito Y, Aihara M, et al. HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Epilepsia 2010; 51: 2461-2465. – reference: Ferrell PB Jr, McLeod HL. Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics 2008; 9: 1543-1546. – reference: Shi YW, Min FL, Liu XR, et al. HLA-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population. Basic Clin Pharmacol Toxicol 2011; 109: 42-46. – reference: Wu XT, Hu FY, An DM, et al. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China. Epilepsy Behav 2010; 19: 405-408. – volume: 75 start-page: 579 year: 2009 end-page: 582 article-title: Association of HLA‐B*1502 allele and carbamazepine‐induced Stevens–Johnson syndrome among Indians publication-title: Indian J Dermatol Venereol Leprol – volume: 127 start-page: 839 year: 1991 end-page: 842 article-title: Toxic epidermal necrolysis and Stevens–Johnson syndrome. An epidemiologic study from West Germany publication-title: Arch Dermatol – volume: 19 start-page: 405 year: 2010 end-page: 408 article-title: Association between carbamazepine‐induced cutaneous adverse drug reactions and the allele among patients in central China publication-title: Epilepsy Behav – volume: 51 start-page: 926 year: 2010 end-page: 930 article-title: Association between and carbamazepine‐induced severe cutaneous adverse drug reactions in a Thai population publication-title: Epilepsia – volume: 20 start-page: 431 year: 2011 end-page: 432 article-title: Phenytoin‐induced Stevens–Johnson syndrome with negative HLA‐B*1502 allele in mainland China: two cases publication-title: Seizure – volume: 77 start-page: 2025 year: 2011 end-page: 2033 article-title: Severe cutaneous adverse reactions to antiepileptic drugs in Asians publication-title: Neurology – volume: 29 start-page: 290 year: 2011 end-page: 293 article-title: Frequency of the allele contributing to carbamazepine‐induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients publication-title: Asian Pac J Allergy Immunol – volume: 49 start-page: 2087 year: 2008 end-page: 2091 article-title: Carbamazepine and phenytoin induced Stevens–Johnson syndrome is associated with HLA‐B*1502 allele in Thai population publication-title: Epilepsia – volume: 18 start-page: 99 year: 2008 end-page: 107 article-title: A European study of HLA‐B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high‐risk drugs publication-title: Pharmacogenet Genomics – volume: 20 start-page: 390 year: 2011 end-page: 391 article-title: HLA‐B*1502 genotyping in two Chinese patients with phenytoin‐induced Stevens–Johnson syndrome publication-title: Epilepsy Behav – volume: 126 start-page: 1103 year: 1990 end-page: 1104 article-title: Incidence of toxic epidermal necrolysis in Italy publication-title: Arch Dermatol – volume: 428 start-page: 486 year: 2004 article-title: Medical genetics: a marker for Stevens–Johnson syndrome publication-title: Nature – volume: 11 start-page: 349 year: 2010 end-page: 356 article-title: Common risk allele in aromatic antiepileptic‐drug induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Han Chinese publication-title: Pharmacogenomics – volume: 12 start-page: 202 year: 2012 end-page: 208 article-title: HLA‐B*1502 strongly predicts carbamazepine‐induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain publication-title: Pain Pract – volume: 92 start-page: 757 year: 2012 end-page: 765 article-title: HLA genotype and carbamazepine‐induced cutaneous adverse drug reactions: a systematic review publication-title: Clin Pharmacol Ther – volume: 48 start-page: 1015 year: 2007 end-page: 1018 article-title: Association between allele and antiepileptic drug‐induced cutaneous reactions in Han Chinese publication-title: Epilepsia – volume: 20 start-page: 446 year: 2011 end-page: 448 article-title: Association between allele and carbamazepine‐induced severe cutaneous adverse reactions in Han people of southern China mainland publication-title: Seizure – volume: 9 start-page: 1543 year: 2008 end-page: 1546 article-title: Carbamazepine, HLA‐B*1502 and risk of Stevens–Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations publication-title: Pharmacogenomics – volume: 35 start-page: 683 year: 2008 end-page: 685 article-title: Human leukocyte antigen genotypes in carbamazepine‐induced severe cutaneous adverse drug response in Japanese patients publication-title: J Dermatol – volume: 51 start-page: 297 year: 2010 end-page: 300 article-title: HLA class I markers in Japanese patients with carbamazepine‐induced cutaneous adverse reactions publication-title: Epilepsia – volume: 88 start-page: 616 year: 2008 end-page: 618 article-title: allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions publication-title: Acta Derm Venereol – volume: 126 start-page: 37 year: 1990 end-page: 42 article-title: Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981–1985 publication-title: Arch Dermatol – volume: 109 start-page: 42 year: 2011 end-page: 46 article-title: alleles and lamotrigine‐induced cutaneous adverse drug reactions in the Han Chinese population publication-title: Basic Clin Pharmacol Toxicol – volume: 51 start-page: 2461 year: 2010 end-page: 2465 article-title: HLA‐B*1511 is a risk factor for carbamazepine‐induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese patients publication-title: Epilepsia – volume: 123 start-page: 1166 year: 1987 end-page: 1170 article-title: The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome) publication-title: Arch Dermatol – volume: 39 start-page: 1521 year: 2011 end-page: 1532 article-title: Toxic epidermal necrolysis and Stevens–Johnson syndrome: a review publication-title: Crit Care Med – volume: 19 start-page: 661 year: 2009 end-page: 665 article-title: High‐resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine‐treated patients publication-title: Pharmacogenet Genomics – volume: 6 start-page: 265 year: 2006 end-page: 268 article-title: A marker for Stevens–Johnson syndrome..: ethnicity matters publication-title: Pharmacogenomics J – volume: 50 start-page: 221 year: 2011 end-page: 224 article-title: Association of HLA‐B*1502 allele with carbamazepine‐induced toxic epidermal necrolysis and Stevens–Johnson syndrome in the multi‐ethnic Malaysian population publication-title: Int J Dermatol – volume: 364 start-page: 1126 year: 2011 end-page: 1133 article-title: Carbamazepine‐induced toxic effects and screening in Taiwan publication-title: N Engl J Med – volume: 331 start-page: 1272 year: 1994 end-page: 1285 article-title: Severe adverse cutaneous reactions to drugs publication-title: N Engl J Med – volume: 126 start-page: 43 year: 1990 end-page: 47 article-title: The incidence of erythema multiforme, Stevens–Johnson syndrome, and toxic epidermal necrolysis. A population‐based study with particular reference to reactions caused by drugs among outpatients publication-title: Arch Dermatol – volume: 127 start-page: 831 year: 1991 end-page: 838 article-title: A population‐based study of Stevens–Johnson syndrome. Incidence and antecedent drug exposures publication-title: Arch Dermatol – volume: 92 start-page: 226 year: 2010 end-page: 230 article-title: Association study of lamotrigine‐induced cutaneous adverse reactions and in a Han Chinese population publication-title: Epilepsy Res – volume: 20 start-page: 1034 year: 2011 end-page: 1041 article-title: Genome‐wide association study identifies allele as a genetic risk factor for carbamazepine‐induced cutaneous adverse drug reactions in Japanese population publication-title: Hum Mol Genet – volume: 67 start-page: 885 year: 2011 end-page: 887 article-title: Strong association between HLA‐B*1502 and carbamazepine‐induced Stevens–Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients publication-title: Eur J Clin Pharmacol – volume: 97 start-page: 190 year: 2011 end-page: 197 article-title: Carbamazepine‐induced severe cutaneous adverse reactions and HLA genotypes in Koreans publication-title: Epilepsy Res – volume: 9 start-page: 1617 year: 2008 end-page: 1622 article-title: HLA‐B locus in Japanese patients with anti‐epileptics and allopurinol‐related Stevens–Johnson syndrome and toxic epidermal necrolysis publication-title: Pharmacogenomics – volume: 126 start-page: 1103 year: 1990 ident: e_1_2_7_3_1 article-title: Incidence of toxic epidermal necrolysis in Italy publication-title: Arch Dermatol doi: 10.1001/archderm.1990.01670320127028 – ident: e_1_2_7_9_1 doi: 10.1038/428486a – ident: e_1_2_7_28_1 doi: 10.1111/j.1346-8138.2008.00548.x – ident: e_1_2_7_12_1 doi: 10.1111/j.1528-1167.2007.01022.x – ident: e_1_2_7_22_1 doi: 10.1016/j.seizure.2011.02.003 – ident: e_1_2_7_23_1 doi: 10.1111/j.1528-1167.2010.02533.x – ident: e_1_2_7_26_1 doi: 10.4103/0378-6323.57718 – ident: e_1_2_7_29_1 doi: 10.1111/j.1528-1167.2010.02766.x – ident: e_1_2_7_8_1 doi: 10.1212/WNL.0b013e31823b478c – ident: e_1_2_7_19_1 doi: 10.1111/j.1365-4632.2010.04745.x – ident: e_1_2_7_33_1 doi: 10.1016/j.eplepsyres.2011.08.010 – ident: e_1_2_7_34_1 doi: 10.1038/sj.tpj.6500356 – ident: e_1_2_7_15_1 doi: 10.1097/CCM.0b013e31821201ed – ident: e_1_2_7_21_1 doi: 10.1007/s00228-011-1009-4 – ident: e_1_2_7_39_1 doi: 10.1111/j.1528-1167.2008.01719.x – ident: e_1_2_7_10_1 doi: 10.1097/FPC.0b013e3282f3ef9c – ident: e_1_2_7_17_1 – ident: e_1_2_7_35_1 doi: 10.1038/clpt.2012.189 – ident: e_1_2_7_24_1 doi: 10.1111/j.1533-2500.2011.00479.x – ident: e_1_2_7_27_1 doi: 10.1093/hmg/ddq537 – ident: e_1_2_7_31_1 doi: 10.2217/14622416.9.11.1617 – volume: 123 start-page: 1166 year: 1987 ident: e_1_2_7_41_1 article-title: The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome) publication-title: Arch Dermatol doi: 10.1001/archderm.1987.01660330077013 – ident: e_1_2_7_16_1 – ident: e_1_2_7_7_1 doi: 10.1056/NEJM199411103311906 – ident: e_1_2_7_11_1 doi: 10.1016/j.eplepsyres.2010.10.006 – volume: 88 start-page: 616 year: 2008 ident: e_1_2_7_32_1 article-title: HLA‐B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions publication-title: Acta Derm Venereol doi: 10.2340/00015555-0528 – ident: e_1_2_7_20_1 doi: 10.1056/NEJMoa1009717 – ident: e_1_2_7_4_1 doi: 10.1001/archderm.1990.01670250043005 – ident: e_1_2_7_40_1 doi: 10.1097/FPC.0b013e32832c347d – ident: e_1_2_7_18_1 doi: 10.1016/j.yebeh.2010.08.007 – ident: e_1_2_7_5_1 doi: 10.1001/archderm.1991.01680050083008 – ident: e_1_2_7_38_1 doi: 10.1016/j.seizure.2011.01.005 – ident: e_1_2_7_14_1 doi: 10.1111/j.1742-7843.2011.00681.x – ident: e_1_2_7_30_1 doi: 10.1111/j.1528-1167.2009.02269.x – ident: e_1_2_7_13_1 doi: 10.2217/pgs.09.162 – volume: 29 start-page: 290 year: 2011 ident: e_1_2_7_25_1 article-title: Frequency of the HLA‐B*1502 allele contributing to carbamazepine‐induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients publication-title: Asian Pac J Allergy Immunol – ident: e_1_2_7_37_1 doi: 10.1016/j.yebeh.2010.11.022 – volume: 127 start-page: 831 year: 1991 ident: e_1_2_7_6_1 article-title: A population‐based study of Stevens–Johnson syndrome. Incidence and antecedent drug exposures publication-title: Arch Dermatol doi: 10.1001/archderm.1991.01680050075007 – ident: e_1_2_7_36_1 doi: 10.2217/14622416.9.10.1543 – ident: e_1_2_7_2_1 doi: 10.1001/archderm.1990.01670250049006 |
| SSID | ssj0013214 |
| Score | 2.2808237 |
| SecondaryResourceType | review_article |
| Snippet | Background
Despite several studies investigating the association between the human leukocyte antigen HLA‐B*1502 allele and lamotrigine‐induced Stevens–Johnson... Despite several studies investigating the association between the human leukocyte antigen HLA-B*1502 allele and lamotrigine-induced Stevens-Johnson syndrome... |
| SourceID | proquest pubmed crossref wiley istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 488 |
| SubjectTerms | Alleles Anticonvulsants - adverse effects Asian Continental Ancestry Group - genetics HLA-B15 Antigen - genetics Humans Stevens-Johnson Syndrome - etiology Stevens-Johnson Syndrome - genetics Triazines - adverse effects |
| Title | Association of HLA-B1502 allele with lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese subjects: a meta-analysis |
| URI | https://api.istex.fr/ark:/67375/WNG-LL2Z12X4-R/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fijd.12570 https://www.ncbi.nlm.nih.gov/pubmed/25428396 https://www.proquest.com/docview/1666723605 |
| Volume | 54 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3datRAFB5KBfFGrb9brZyKiDdZkkky2dGr1v6sZe1FqbiIMMxkZmDtmpQmC8WrPoLgE_hqfZKemfywlQriXSAnyWTmnMx3Zk6-j5BXyUhiVqBpYDXHBIXxNJCRSoIIJ2vGubKR9tUWh2z8KTmYptMV8q77F6bhh-gX3Fxk-O-1C3CpqqUgn33Tw8hpsOH319VqOUB0RJd2EBpeb7cEyBFDtKxCroqnv_LaXHTLdev5TUDzOm71E8_ePfK1a3JTb3IyXNRqmP_4g83xP9_pPrnbAlLYajxojayY4gG5_bHdcn9Ifi8NIJQWxpOty4uf24jwKDgdlrkBt5YL6Fll7VW2DJ7HTB99RkMjmlZdXvxqpbigo0gAWWioy_NZDsap1OIEMYcCQWzpSVJgVsBYFuD0vU1loFoot2JUvQUJ300t8Rmy5VN5RI73do_fj4NW1yHIYxaHgQ5tpCJFY4XwxYQ25pjF4YBJBGs6iRXXuU2oZVGOnmJkIkeWGhOyUGK2mur4MVktysI8JTDKLA-1VTbN44ShIR9lubLSGqazkMkBedMNsMhbznMnvTEXXe6DPS58jw_Iy970tCH6uMnotfeS3kKenbjKuCwVnw_3xWRCv0R0moijAdns3EhgvLpNGFmYclEJt02b0RizyAF50vhXfzdM1hHtcYbN9l7y94aIDwc7_mD9302fkTuI9tKm7Og5Wa3PFmYDEVWtXvjQuQLeMSBz |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbhMxELVKKwEv3KHhOiCEeNlor06MeCmXsi3bPFRBRJWQZa9tKW3YRd2NVPHUT0DiC_i1fglj70UpKhLibaXMZr32THzOeDKHkOfxWCArUKFnFEOCQlniiUDGXoCbNWVMmkC5aosJTT_Fu7NktkZed_-FafpD9Ak3Gxnu99oGuE1Ir0T5_FANAyvCdolsWEVvR6j2w5UzhKazt00CMkQRbV8hW8fT33puN9qwE3tyEdQ8j1zd1rN9nXzpBt1UnBwNl7Uc5t__6Of4v291g1xrMSlsNU50k6zp4ha5vNeeut8mv1bWEEoDabZ1dvrjDYK8EKwUy0KDTecCOldZO6EtjZ8j2Ue3UdDoplVnpz9bNS7ouiSAKBTU5ck8B22FanGPWECBOLZ0fVJgXkAqCrAS37rSUC2lTRpVr0DAV10LfIZoW6rcIdPt99O3qddKO3h5RCPfU74JZCDDSCKC0b6JGBI5XDGBeE3FkWQqN3FoaJCjs2gRi7EJtfapL5CwJiq6S9aLstCbBMYjw3xlpEnyKKZoyMajXBphNFUjn4oBedmtMM_btudWfWPBO_qDM87djA_Is970W9Pr4yKjF85NegtxfGSL40YJ_zz5wLMsPAjCWcz3B-Rp50ccQ9aew4hCl8uK25PaURghkRyQe42D9d-GfB0BH6M4bOcmfx8I39l95y7u_7vpE3Ilne5lPNuZfHxAriL4S5oqpIdkvT5e6kcIsGr52MXRb7mbJI4 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bahsxEB3SBEJfer-4V7WU0pc1e9Wu2qe0ruukrikhpSYUhLSSwImzG-I1hD7lEwr9gv5avqQj7QWnpFD6ZvDYlqUz1hlpfA7AizgTWBWo0DOKYYFCWeKJQMZegJs1ZUyaQLluiwkdfYl3psl0Dd60_4Wp9SG6AzebGe732ib4sTIrST47UP3AerBdgY2Y-pmF9GA3XLlCqIW97RkgQxLRyArZNp7upRc2ow07r6eXMc2LxNXtPMPr8K0dc91wcthfVrKff_9DzvE_v9QNuNYwUrJVQ-gmrOniFmx-au7cb8OvlRUkpSGj8db52Y-3SPFCYo1Y5prYw1yC0CorZ7Ol8Xks9RE0itSuaYvzs5-NFxdpNRKIKBSpytNZTrS1qcUdYk4KZLGlU0khs4KMREGswbdeaLJYSntktHhNBDnSlcDPEI2gyh3YG77fezfyGmMHL49o5HvKN4EMZBhJ5C_aNxHDMg4XTCBbU3EkmcpNHBoa5AgVLWKRmVBrn_oCy9VERXdhvSgLfR9IlhrmKyNNkkcxxUCWpbk0wmiqUp-KHrxqF5jnjei59d6Y87b4wRnnbsZ78LwLPa6VPi4LeulQ0kWIk0PbGpcm_OvkAx-Pw_0gnMZ8twfPWhhxTFh7CyMKXS4X3N7TpmGEZWQP7tX46t4Nq3Wke4zisB1K_j4Qvr0zcA8e_HvoU9j8PBjy8fbk40O4iswvqVuQHsF6dbLUj5FdVfKJy6LfXrQjRg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+HLA+%E2%80%90B1502+allele+with+lamotrigine%E2%80%90induced+Stevens%E2%80%93Johnson+syndrome+and+toxic+epidermal+necrolysis+in+Han+Chinese+subjects%3A+a+meta%E2%80%90analysis&rft.jtitle=International+journal+of+dermatology&rft.au=Zeng%2C+Tao&rft.au=Long%2C+Yue%E2%80%90Sheng&rft.au=Min%2C+Fu%E2%80%90Li&rft.au=Liao%2C+Wei%E2%80%90Ping&rft.date=2015-04-01&rft.issn=0011-9059&rft.eissn=1365-4632&rft.volume=54&rft.issue=4&rft.spage=488&rft.epage=493&rft_id=info:doi/10.1111%2Fijd.12570&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_ijd_12570 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0011-9059&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0011-9059&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0011-9059&client=summon |